UnknownNot Applicable

The Value of Placental Vascularization and Placental Volume in Pregnancy in APLS

Egypt100 participantsStarted 2018-04-24

Plain-language summary

Antiphospholipid antibodies are autoantibodies directed against phospholipid-binding proteins. Among these groups of antibodies, lupus anticoagulant (LA) and anticardiolipin antibodies (aCL)

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Singleton pregnancy. * Gestational age of 34-37 weeks. * Pregnant women with antiphospholipid syndrome Exclusion Criteria: * Twin or multiple pregnancies. * Congenital fetal anomalies. * Gestational age of less than 34. * Gestational age of more than 37. * Women with placental or umbilical artery anomalies. * Antepartum hemorrhage (placental abruption, placenta previa and vasa previa). * Posterior placenta. * History of rupture of membrane. * Patient refusal or fall outs.

What they're measuring

The number of participants who will have impaired placental doppler indices

Timeframe: within 2 months

Trial details

NCT IDNCT03505840

SponsorAljazeera Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-09-04

Contact for this trial

Mahmoud Alalfy

01002611058 mahmoudalalfy@ymail.com

View on ClinicalTrials.gov More Antiphospholipid Syndrome in Pregnancy trials